Articles related to GUIDELINES/RECOMMENDATIONS

As pharmacists, it’s crucial to note that, although these changes in FDA guidelines may not directly impact your practice, they signify a shift in how biosimilars will be identified moving forward. This could potentially influence how you advise patients about these products.

The introduction of these new guidelines marks a significant advancement in our understanding and determination of brain death. An emphasis on standardization and accuracy, these guidelines could change how we approach this critical aspect of medical practice.

Stay informed about the increasing prevalence of xylazine in illegally manufactured fentanyl. Learn about its impact on patient care and discover strategies for effective treatment and harm reduction.

Stay updated on the USPSTF’s stance on lipid disorder screening in asymptomatic youth—a topic that directly impacts our strategies for early detection and intervention.

ACIP’s endorsement of Abrysvo offers a new preventive measure against RSV in infants, urging healthcare providers to discuss this option with expectant parents.

Stay abreast of the latest evidence-based practices to prevent surgical site infections with the newly updated guidelines, aimed at achieving zero harm in acute care settings.